Literature DB >> 9726051

Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistochemical study.

H K Ng1, L Chen.   

Abstract

AIMS: Although necrosis is an important phenomenon with implications for grading and prognostication in meningiomas, the alternate form of cell death, apoptosis, has not been extensively studied. In this series, we aimed to determine whether apoptosis in meningiomas correlated with histological types and grading. We also looked for a relationship between expression of apoptosis-related genes bcl-2, p53, c-myc and apoptosis meningiomas. METHODS AND
RESULTS: Fifty-one meningiomas of diverse histological subtypes and grades were investigated with in situ end-labelling of DNA fragments as well as immunohistochemical analysis of three apoptosis-related genes: p53, bcl-2 and c-myc. Our results showed that the apoptosis index was significantly higher in high-grade meningiomas (0.12%, n = 12) in than the benign meningiomas (0.023%, n = 39) P = 0.001) but there was no difference among the different histological subtypes of the benign meningiomas (P = 0.125). There is no obvious relationship between p53, bcl-2 and c-myc staining and apoptosis index in this group of meningiomas.
CONCLUSION: We conclude that apoptosis is an important phenomenon in meningiomas and that it is associated with atypical or malignant changes in meningiomas. Apoptosis in meningiomas has no clearcut relationship with expression of p53, bcl-2 and c-myc.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726051     DOI: 10.1046/j.1365-2559.1998.00440.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

1.  Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas.

Authors:  A Konstantinidou; P Korkolopoulou; E Patsouris; H Mahera; S Hranioti; X Kotsiakis; P Davaris
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  The histopathological spectrum of human meningiomas.

Authors:  Thomas Backer-Grøndahl; Bjørnar H Moen; Sverre H Torp
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

3.  Meningiomas in Singapore: demographic and biological characteristics.

Authors:  A Das; W Y Tang; D R Smith
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

4.  Progesterone receptor, bc1-2 and bax expression in meningiomas.

Authors:  F M Verheijen; G H Donker; C Sales Viera; M Sprong; H M Jacobs; G Blaauw; J H H Thijssen; M A Blankenstein
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

5.  Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation.

Authors:  S Weisberg; E Ashkenazi; Z Israel; M Attia; Y Shoshan; F Umansky; C Brodie
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  Absence of histological signs of tumor progression in recurrences of completely resected meningiomas.

Authors:  Davide Schiffer; Chiara Ghimenti; Valentina Fiano
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

7.  Diagnostic impact of ornithine decarboxylase in meningiomas.

Authors:  Werner Stenzel; Gabriele Röhn; Hrvoje Miletic; Herbert Radner; Martina Deckert; Ralf-Ingo Ernestus
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

8.  Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence.

Authors:  B R Ongaratti; C B O Silva; G Trott; T Haag; C G S Leães; N P Ferreira; M C Oliveira; J F S Pereira-Lima
Journal:  Braz J Med Biol Res       Date:  2016-03-18       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.